Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 USD | +0.46% | -5.22% | +26.01% |
08/05 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
08/05 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.01% | 13Cr | |
+5.54% | 11TCr | |
+11.02% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.43% | 1.69TCr | |
+2.82% | 1.38TCr | |
+35.23% | 1.25TCr |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- Transcript : Karyopharm Therapeutics Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 05